methylprednisolone and cyclophosphamide
Showing 1 - 25 of 2,306
Idiopathic Membranous Nephropathy Trial in Beijing (Prednisone, MP and CTX)
Terminated
- Idiopathic Membranous Nephropathy
- Prednisone
- MP and CTX
-
Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Feb 2, 2022
ANCA Associated Vasculitis Trial in Netherlands (Rituximab, endoxan, Methylprednisolone)
Recruiting
- ANCA Associated Vasculitis
- Rituximab
- +3 more
-
Leiden, Zuid-Holland, Netherlands
- +3 more
May 16, 2022
Lymphoma, Lymphoma, Large B-Cell, Diffuse Trial in Boston (Glofitamab, Polatuzumab, Rituximab)
Not yet recruiting
- Lymphoma
- Lymphoma, Large B-Cell, Diffuse
- Glofitamab
- +5 more
-
Boston, Massachusetts
- +1 more
Apr 4, 2023
Fanconi Anemia, Severe Aplastic Anemia, MDS Trial in Minneapolis (Total Body Irradiation (TBI) (Plan 1), Cyclophosphamide (CY)
Recruiting
- Fanconi Anemia
- +2 more
- Total Body Irradiation (TBI) (Plan 1)
- +8 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Nov 2, 2022
Systemic Lupus Erythematosus Trial (Telitacicept, Hydroxychloroquine, Prednisone)
Not yet recruiting
- Systemic Lupus Erythematosus
- Telitacicept
- +6 more
- (no location specified)
Dec 28, 2022
Crohn Disease Trial in Los Angeles (drug, procedure, biological)
Recruiting
- Crohn Disease
- Mesna
- +12 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Mar 23, 2022
Leukemia Trial in Portland (cyclophosphamide, cytarabine, dexamethasone)
Terminated
- Leukemia
- cyclophosphamide
- +8 more
-
Portland, OregonOHSU Knight Cancer Institute
Dec 13, 2022
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma Trial (Cyclophosphamide, Vincristine, Dexamethasone)
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- B Lymphoblastic Lymphoma
- Cyclophosphamide
- +10 more
- (no location specified)
Aug 2, 2022
Fanconi Anemia Trial in Minneapolis (biological, drug, procedure)
Completed
- Fanconi Anemia
- Anti-Thymocyte Globulin
- +7 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Oct 8, 2021
Systemic Lupus Erythematosus (SLE) Trial in São Paulo (Cyclophosphamide, Methylprednisolone, Prednisone)
Terminated
- Systemic Lupus Erythematosus (SLE)
- Cyclophosphamide
- +3 more
-
São Paulo, Sao Paulo, Brazil
- +1 more
Jul 14, 2021
Fanconi Anemia Trial in Minneapolis (anti-thymocyte globulin, filgrastim, busulfan)
Completed
- Fanconi Anemia
- anti-thymocyte globulin
- +6 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Nov 4, 2021
Clinical Prognosis and Progression of Myasthenia Gravis Patients
Recruiting
- Myasthenia Gravis
- Symptomatic Treatment, Steroids, Immunosuppressive Agents, Plasma Exchange(PE), Intravenous Immunoglobulin(IVIg)
-
Beijing, Beijing, ChinaXuan Wu Hospital, Capital Medical University
Aug 19, 2021
Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage I Adult
Completed
- Contiguous Stage II Adult Lymphoblastic Lymphoma
- +5 more
- carfilzomib
- +10 more
-
Sacramento, CaliforniaUniversity of California Davis
Mar 8, 2022
DLBCL, High Grade B-Cell Lymphoma w/MYC & BCL2 or BCL6 Rearrangements, High Grade B-Cell Lymphoma w/MYC, BCL2 & BCL6
Recruiting
- Diffuse Large B-Cell Lymphoma
- +2 more
- Prednisone
- +6 more
-
Tampa, Florida
- +1 more
Jan 12, 2022
Advanced Follicular Lymphoma Trial in Worldwide (Obinutuzumab, Bendamustine, Cyclophosphamide)
Active, not recruiting
- Advanced Follicular Lymphoma
- Obinutuzumab
- +5 more
-
Boulder, Colorado
- +33 more
Nov 21, 2022
Drug/Agent Toxicity by Tissue/Organ, Leukemia Trial in Canada, Puerto Rico, United States (asparaginase, cyclophosphamide,
Completed
- Drug/Agent Toxicity by Tissue/Organ
- Leukemia
- asparaginase
- +15 more
-
Boston, Massachusetts
- +9 more
Nov 9, 2022
Multiple Sclerosis, Relapsing-Remitting Trial in Chicago (Cyclophosphamide, Mesna, rATG)
Terminated
- Multiple Sclerosis, Relapsing-Remitting
- Cyclophosphamide
- +6 more
-
Chicago, IllinoisNorthwestern University
Jan 6, 2021
Leukemia, Acute Lymphoblastic Leukemia Trial in Houston (Rituximab, Cyclophosphamide (CTX), Doxorubicin)
Completed
- Leukemia
- Acute Lymphoblastic Leukemia
- Rituximab
- +11 more
-
Houston, TexasUT MD Anderson Cancer Center
Dec 1, 2020
Lupus Erythematosus, Systemic Trial run by the NCI (drug, biological, other, procedure)
Completed
- Lupus Erythematosus, Systemic
- fludarabine phosphate
- +9 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 9, 2020
Stiff-Person Syndrome Trial in Chicago (Autologous Hematopoietic Stem Cells, Cyclophosphamide, Mesna)
Terminated
- Stiff-Person Syndrome
- Autologous Hematopoietic Stem Cells
- +6 more
-
Chicago, IllinoisNorthwestern University
Jan 6, 2021
Scleroderma, Systemic Trial in Chicago (Peripheral Blood Stem Cells, Cyclophosphamide, Mesna)
Terminated
- Scleroderma, Systemic
- Peripheral Blood Stem Cells
- +6 more
-
Chicago, IllinoisNorthwestern University
Jul 7, 2020